Inventor · disambiguated record
James D. Pipkin
Also filed as: PIPKIN JAMES D
33 granted patents·18 pending applications·839 citations·filing 1986–2023
97Inventor score
Top patents by PatentIndex Score
51 records- 0198US7629331B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2009·Granted Dec 8, 2009·68 cites·18 claims
- 0296US5882682AControlled release simvastatin delivery deviceMERCK & CO INC·Filed 1995·Granted Mar 16, 1999·206 cites·28 claims
- 0395US8114438B2DPI formulation containing sulfoalkyl ether cyclodextrinPIPKIN JAMES D·Filed 2006·Granted Feb 14, 2012·40 cites·11 claims
- 0495US5366738AControlled release drug dispersion delivery deviceMERCK & CO INC·Filed 1993·Granted Nov 22, 1994·207 cites·18 claims
- 0594US8049003B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2008·Granted Nov 1, 2011·18 cites·20 claims
- 0692US8829182B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·7 cites·24 claims
- 0791US5582838AControlled release drug suspension delivery deviceMERCK & CO INC·Filed 1994·Granted Dec 10, 1996·139 cites·23 claims
- 0890US10702568B2Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the sameUNIV KANSAS·Filed 2016·Granted Jul 7, 2020·2 cites·13 claims
- 0990US8846901B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofMOSHER GEROLD L·Filed 2011·Granted Sep 30, 2014·5 cites·27 claims
- 1090US4946838ACrystalline anhydrous aztreonamSQUIBB & SONS INC·Filed 1986·Granted Aug 7, 1990·38 cites·6 claims
- 1189US10202468B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·2 cites·25 claims
- 1289US7829114B2Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrinCYDEX PHARMACEUTICALS INC·Filed 2005·Granted Nov 9, 2010·10 cites·19 claims
- 1386US10799599B2Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidCYDEX PHARMACEUTICALS INC·Filed 2018·Granted Oct 13, 2020·1 cites·12 claims
- 1486US10703826B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·1 cites·20 claims
- 1584US10940128B2Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 9, 2021·2 cites·14 claims
- 1684US7235258B1Sustained-release formulations for treating CNS-mediated disordersNPS PHARMA INC·Filed 2000·Granted Jun 26, 2007·17 cites·8 claims
- 1783US11382944B2Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the sameCYDEX PHARMACEUTICALS INC·Filed 2020·Granted Jul 12, 2022·1 cites·25 claims
- 1883US10207008B2Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidCYDEX PHARMACEUTICALS INC·Filed 2017·Granted Feb 19, 2019·2 cites·21 claims
- 1983US10159752B2Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidCYDEX PHARMACEUTICALS INC·Filed 2012·Granted Dec 25, 2018·4 cites·14 claims
- 2082US2024139137A1Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the SameCYDEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2182US2024156766A1Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2281US10117940B2DPI formulation containing sulfoalkyl ether cyclodextrinCYDEX PHARMACEUTICALS INC·Filed 2013·Granted Nov 6, 2018·3 cites·17 claims
- 2381US9617352B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2014·Granted Apr 11, 2017·3 cites·18 claims
- 2480US5543154AControlled release nifedipine delivery deviceMERCK & CO INC·Filed 1994·Granted Aug 6, 1996·54 cites·16 claims
- 2579US10668160B2DPI formulation containing sulfoalkyl ether cyclodextrinPIPKIN JAMES D·Filed 2011·Granted Jun 2, 2020·1 cites·14 claims
- 2678US10864183B2Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·0 cites·10 claims
- 2777US12390506B2Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the sameCYDEX PHARMACEUTICALS INC·Filed 2022·Granted Aug 19, 2025·0 cites·26 claims
- 2877US9827324B2Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidPIPKIN JAMES D·Filed 2012·Granted Nov 28, 2017·2 cites·3 claims
- 2975US9358297B2Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrinMERCK SHARP & DOHME·Filed 2015·Granted Jun 7, 2016·2 cites·34 claims
- 3074US10463677B2Composition containing sulfoalkyl ether cyclodextrin and latanoprostESAKI NAOMI·Filed 2008·Granted Nov 5, 2019·2 cites·19 claims
- 3171US11433082B2Composition containing sulfoalkyl ether cyclodextrin and latanoprostCYDEX PHARMACEUTICALS INC·Filed 2019·Granted Sep 6, 2022·0 cites·44 claims
- 3271US11020363B2Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2014·Granted Jun 1, 2021·0 cites·7 claims
- 3371US2021379000A1Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3470US2021046033A1Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the SameCYDEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3570US2023255919A1Composition containing cyclodextrin and busulfanCYDEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3668US11464862B2DPI formulation containing sulfoalkyl ether cyclodextrinCYDEX PHARMACEUTICALS INC·Filed 2020·Granted Oct 11, 2022·0 cites·16 claims
- 3768US2019192684A1Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidCYDEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3868US2022387444A1Composition containing sulfoalkyl ether cyclodextrin and latanoprostCYDEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3966US9023790B2Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrinHEIMBECHER SUSAN K·Filed 2011·Granted May 5, 2015·2 cites·19 claims
- 4061US2007202054A1Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and CorticosteroidPIPKIN JAMES D·Filed 2006·Application pending·0 cites
- 4160US2007020196A1Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspensionPIPKIN JAMES D·Filed 2006·Application pending·0 cites
- 4260US2009312724A1Nasal and Ophthalmic Delivery of Aqueous Corticosteroid SolutionsCYDEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4359US2007020299A1Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidPIPKIN JAMES D·Filed 2006·Application pending·0 cites
- 4457US2011123518A1Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and CorticosteroidCYDEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4557US2011251157A1Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and CorticosteroidCYDEX PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 4656US2005164986A1Use of sulfoalkyl ether cyclodextrin as a preservativeFiled 2003·Application pending·0 cites
- 4755US12370352B2Nasal and ophthalmic delivery of aqueous corticosteroid solutionsCYDEX PHARMACEUTICALS INC·Filed 2021·Granted Jul 29, 2025·0 cites·9 claims
- 4852US2007020298A1Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroidPIPKIN JAMES D·Filed 2006·Application pending·0 cites
- 4951US2010311838A1Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the SamePIPKIN JAMES D·Filed 2010·Application pending·0 cites
- 5051US2011008325A1Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid Prepared from a Unit Dose SuspensionCYDEX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James D. Pipkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →